SAN FRANCISCO, Sept. 20, 2016 /PRNewswire/ -- Kindred
Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company
focused on saving and improving the lives of pets, today
announced Dr. Richard Chin,
President and CEO, will be presenting at the Ladenburg Thalmann
Healthcare Conference in New York
City on Tuesday, September 27,
2016 at 11:00 AM EDT. The
conference is being held at the Sofitel Hotel.
The presentation will be available via a live webcast at the
following URL: http://wsw.com/webcast/ladenburg2/kin.
An archived version of the webcast and presentation will be
available for 30 days on the Company's website:
http://kindredbio.com/investor-relations/events.
About Kindred Biosciences, Inc.
Kindred Biosciences is a development-stage biopharmaceutical
company focused on saving and improving the lives of pets.
Its mission is to bring to pets the same kinds of safe and
effective medicines that human family members enjoy. The
Company's strategy is to identify compounds and targets that have
already demonstrated safety and efficacy in humans and to develop
therapeutics based on these validated compounds and targets for
dogs, cats and horses. The Company has a deep pipeline of
novel drugs and biologics in development across many therapeutic
classes.
For more information or to download the corporate presentation,
visit www.KindredBio.com/LearnMore. Stay connected with KindredBio
on Facebook at www.Facebook.com/KindredBio.
Contact
Russell Radefeld
KindredBio
Russell.radefeld@kindredbio.com
(650) 701-7904
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/kindred-biosciences-to-present-at-2016-ladenburg-thalmann-healthcare-conference-300330646.html
SOURCE Kindred Biosciences, Inc.